Stable Isotope Labeled Ustekinumab Biosimilar – Anti-Human IL-12 IL-23 mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Stable Isotope Labeled Ustekinumab Biosimilar - Anti-Human IL-12 IL-23 mAb - Research Grade |
|---|---|
| Source | DrugBank DB05679 |
| Species | Human |
| Expression system | Mammalian cells |
| Molecular weight | 148kDa |
| Purity | >90% |
| Buffer | PBS pH7.5 |
| Delivery condition | Blue Ice |
| Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
| Storage condition | 4°C for short term; -20°C for long term |
| Brand | ProteoGenix |
| Aliases /Synonyms | Ustekinumab |
| Reference | PX-TA1011-SIL |
| Related Products | PX-P4570,PX-P5123 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1 |
| Clonality | Monoclonal Antibody |
| Format | Lyophilized |
| Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2 |
| Isotopic Enrichment | 99% |
| Stability | 1 year |
General information about Ustekinumab
Ustekinumab is a human monoclonal antibody used to treat psoriasis. It is also approved to treat Crohn’s disease and ulcerative colitis among people who have not responded to more traditional treatments. It is a subcutaneous human interleukin 12 and interleukin 23 antagonist. These are naturally occurring proteins that regulate the immune system and immune-mediated inflammatory disorders. This product is for research use only.
Related products
Antigen CD47 Recombinant Protein (Human) PX-P4083 426$
Antigen Human Human DCLK3 partial (162-632) Recombinant Protein PX-P2075 221$
Antigen Human TIVAMP Human Recombinant Protein PX-P1161 221$
Antigen Interleukin-2（Il2） PX-P4637 221$
Isotype Control Human IgG1 LALA Isotype Control antibody (HyHEL-10) PTX17885-100 189$
Biosimilar Ustekinumab Biosimilar – Anti-Human IL-12 IL-23 mAb – Research Grade PX-TA1011 357$
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.